344 related articles for article (PubMed ID: 7438976)
1. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.
Haslam RH; Sass-Kortsak A; Stout W; Berg M
Dev Pharmacol Ther; 1980; 1(5):318-24. PubMed ID: 7438976
[TBL] [Abstract][Full Text] [Related]
2. The management of Wilson's disease with trienthylene tetramine 2HC1 (Trien 2HC1).
Walshe JM
Prog Clin Biol Res; 1979; 34():271-80. PubMed ID: 531055
[No Abstract] [Full Text] [Related]
3. [Triethylene tetramine in Wilson's disease].
Rave D; Vengrover D; Kleinman J; Leitersdorf E
Harefuah; 1986 Feb; 110(4):178-9. PubMed ID: 3721331
[No Abstract] [Full Text] [Related]
4. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Wilson's disease.
Brewer GJ; Yuzbasiyan-Gurkan V; Young AB
Semin Neurol; 1987 Jun; 7(2):209-20. PubMed ID: 3332455
[No Abstract] [Full Text] [Related]
6. Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine).
Dahlman T; Hartvig P; Löfholm M; Nordlinder H; Lööf L; Westermark K
QJM; 1995 Sep; 88(9):609-16. PubMed ID: 7583074
[TBL] [Abstract][Full Text] [Related]
7. Neurological abnormalities in Wilson's disease are reversible.
Lingam S; Wilson J; Nazer H; Mowat AP
Neuropediatrics; 1987 Feb; 18(1):11-2. PubMed ID: 3561699
[TBL] [Abstract][Full Text] [Related]
8. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
9. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease.
Scheinberg IH; Jaffe ME; Sternlieb I
N Engl J Med; 1987 Jul; 317(4):209-13. PubMed ID: 3600712
[TBL] [Abstract][Full Text] [Related]
10. [Trientin in Wilson's disease. Therapeutic possibilities in patients who cannot tolerate penicillamine].
Ritland S
Tidsskr Nor Laegeforen; 1987 Aug; 107(22):1770-1. PubMed ID: 3660361
[No Abstract] [Full Text] [Related]
11. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.
Walshe JM
Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043
[No Abstract] [Full Text] [Related]
12. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride.
Walshe JM
Lancet; 1982 Mar; 1(8273):643-7. PubMed ID: 6121964
[TBL] [Abstract][Full Text] [Related]
13. Triethylene tetramine dihydrochloride toxicity in primary biliary cirrhosis.
Epstein O; Sherlock S
Gastroenterology; 1980 Jun; 78(6):1442-5. PubMed ID: 6445305
[TBL] [Abstract][Full Text] [Related]
14. Trientine for Wilson's disease.
Med Lett Drugs Ther; 1986 Jul; 28(717):67. PubMed ID: 3724656
[No Abstract] [Full Text] [Related]
15. [Wilson's disease: physiopathology, therapeutic approach and case report].
Gallo V; Riva P; Sidoli L; Bisbocci D
Minerva Gastroenterol Dietol; 1994 Dec; 40(4):197-201. PubMed ID: 7849148
[TBL] [Abstract][Full Text] [Related]
16. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
[TBL] [Abstract][Full Text] [Related]
17. Preparation of and clinical experiences with trien for the treatment of Wilson's disease in absolute intolerance of D-penicillamine.
Harders H; Cohnen E
Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):10-2. PubMed ID: 122652
[No Abstract] [Full Text] [Related]
18. [Control of the therapeutic prevention of copper uptake in the liver in Wilson's disease following oral administration of 64Cu].
Günther K; Siegemund R; Lössner J; Kühn HJ
Radiobiol Radiother (Berl); 1988; 29(2):226-9. PubMed ID: 3399664
[No Abstract] [Full Text] [Related]
19. [Treatment of Wilson's disease using triethylenetetramine dihydrochloride (TETA)].
Hauftová D; Körbel J; Jancík F; Kuhr I; Ferenc M
Cesk Gastroenterol Vyz; 1978 Dec; 32(8):538-9. PubMed ID: 737791
[No Abstract] [Full Text] [Related]
20. Treatment of Wilson's disease with triethylene tetramine hydrochloride (Trientine).
Dubois RS; Rodgerson DO; Hambidge KM
J Pediatr Gastroenterol Nutr; 1990 Jan; 10(1):77-81. PubMed ID: 2324883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
